UK CEO and Investor Forum

Published: 10-May-2016

22 - 23 June 2016

Forum

Down Hall, Hatfield Heath, UK


In this highly focused, invitation only, thought leadership event, the who’s who of the UK life science sector come together to discuss the most pertinent issues, big challenges and opportunities facing the sector today.

Organiser: BIA Bioindustry Association

Trending Articles

  1. ASGCT Annual Meeting 2024 7-11 May, 2024 | Meeting | Portland, OR
  2. CPhI North America 7-9 May 2024 | Exhibition | Pennsylvania, US
  3. Cleanroom Conference UK 22–23 May 2024 | Exhibition | Birmingham, UK
  4. CPhI Worldwide 2011 <b>25 - 27 October 2011</b><br> Messe Frankfurt
  5. Lounges 23-25 April 2024 | Conference | Messe Karlsruhe, Germany

You may also like

Research & Development

The power of national collaboration

To expedite the scale-up and production of a COVID-19 vaccine, the UK BioIndustry Association issued a call to arms to its members, reports Steve Bates, CEO
Regulatory

Waiting in the shadow of a no deal Brexit

Pharmaceutical companies still do not know how they will be impacted by Brexit after Prime Minister Theresa May decided to postpone a vote on her deal with the European Union (EU), writes Paul Brooks, Executive Director, RAPS
Pharmaceutical

UK Bioscience Forum 2018

18 October 2018 | Forum | London, UK
Media

Life Sciences sector responds to report on the impact of Brexit

The Business, Energy and Indsutrial Strategy (BEIS) Committee report calls on the Government to secure a post-Brexit deal to protect patients and the UK's pharmaceutical industry
Regulatory

Life Sciences Industrial Strategy paves way to support UK bioscience growth

The BioIndustry Association (BIA) welcomes the publication of the Life Sciences Industrial Strategy
Media

BIA report shows UK is on track to build the world’s third global biotech cluster

CEO Steve Bates attributes this to an “entrepreneurial and resilient community that is staffed by great management teams”
Media

Triggering Article 50

On 29th March, the UK government triggered Article 50 which officially marks the start of the UK’s exit from the European Union. Home to a world-leading life science industry, the countdown of Britain leaving the EU has inevitably created a stir within the UK’s pharmaceutical industry
Subscribe now